OOIR: Observatory of International Research

Papers

(The TQCC of Critical Reviews in Microbiology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids	94
TREM-2: friend or foe in infectious diseases?	80
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases	68
Salmonella in eggs and egg-laying chickens: pathways to effective control	53
Dynamics of antibiotic resistance genes in plasmids and bacteriophages	51
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19	51
Current and emerging therapies for fungal biofilms and systemic infections	51
Paving the way forward: Escherichia coli bacteriophages in a One Health approach	41
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies	38
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases	38
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication	37
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens	37
Elucidating the multifaceted antibacterial mechanisms of luteolin: insights, challenges, and prospects for clinical translation	36
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections	32
Under the lens: using Raman spectroscopy as a unique system in biofilm analyses	30
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings	30
Exploring halophilic environments as a source of new antibiotics	30
LysR-type transcriptional regulators: state of the art	29
Bile acid–gut microbiota crosstalk in irritable bowel syndrome	26
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review	26
Helicobacter pylori ’s secret resilience: coccoid forms, yeast havens, and outer membrane vesicle release for survival and spread	25
The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma	25
Vibrio cholerae virulence and its suppression through the quorum-sensing system	25
Helicobacter pylori eradication: developing antibiotic-independent antimicrobial moieties	24
The microbiome and precision oncology: an emerging paradigm in anticancer therapy	24

Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria	23
Polyamine as a microenvironment factor in resistance to antibiotics	21
Bacterial vaginosis: advancing insights into microbial dysbiosis	20
Endophytic fungi-bioinspired nanoparticles potential to control infectious disease	19
The role of single and mixed biofilms in Clostridioides difficile infection and strategies for prevention and inhibition	18
The diffusible signaling factor family in microbial signaling: a current perspective	18
Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness	18
Microbial persisters and host: recent advances and future perspectives	17
Phage-bacterial evolutionary interactions: experimental models and complications	17
Emergence of persister cells in Staphylococcus aureus : calculated or fortuitous move?	17
Antibiotic resistance in Pseudomonas aeruginosa : mechanisms and emerging treatment	17
Revisiting the antimicrobial potential of metalloporphyrins: from food to pharma	16
Microbial biosynthesis of nucleos(t)ide analogs: applications, and engineering optimization	16
Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections	16
Quorum sensing in biofilms: a key mechanism to target in ecotoxicological studies	16
Biotherapeutic potential of gut microbiota-derived indole-3-acetic acid	16
Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients	15
Ureaplasma infections: update on epidemiology, antimicrobial resistance, and pathogenesis	15
Advances in mining and expressing microbial biosynthetic gene clusters	15
Current types of staphylococcal cassette chromosome mec (SCC mec ) in clinically relevant coagulase-negative staphylococcal (CoNS) species	14
Review on computer-assisted biosynthetic capacities elucidation to assess metabolic interactions and communication within microbial communities	14
The resilient microbiome: how baseline gut microbial composition influences response to cancer treatment	14
Porphyromonas gingivalis and the pathogenesis of Alzheimer’s disease	13
Mechanisms underlying the effects, and clinical applications, of oral microbiota in lung cancer: current challenges and prospects	13
The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential	13
The potential for bacteriophages and prophage elements in fighting and preventing the gonorrhea	12
Insights into the molecular basis of c-di-GMP signalling in Pseudomonas aeruginosa	12
The crosstalk between SUMOylation and immune system in host-pathogen interactions	12
Anti-virulence peptides: a compromising strategy to treat Staphylococcus aureus chronic wound infection	12
Roles of alcohol dehydrogenase 1 in the biological activities of Candida albicans	12
Community dynamics of subgingival microbiome in periodontitis and targets for microbiome modulation therapy	12
Aspergilli series Versicolores: importance of species identification in the clinical setting	12
Unravelling the sponge microbiome as a promising source of biosurfactants	12